A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus Interventions: Drug: GX-G6; Drug: Control Sponsor: Genexine, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials